Romsons Group Announces Strategic Partnership with Temasek to Accelerate Long-Term Growth
New Delhi: Romsons Group, one of India’s leading brands in the medical devices and hygiene products sector, today announced the successful completion of a strategic private equity transaction with Temasek, a global investment company headquartered in Singapore. The transaction marks a significant milestone in Romsons’ 70-year journey and establishes a strong foundation for the company’s continued expansion.
Temasek has joined Romsons as a long-term strategic partner through a minority investment, bringing together Romsons’ strong Indian healthcare platform and operating capabilities with Temasek’s global experience and long-term investment perspective.
A Partnership for Long-Term Value Creation
The association with Temasek represents more than a capital partnership. It is intended to support Romsons’ ambitions, strengthen its capabilities and create sustainable value as the company expands its presence across India and international markets.
Over the past seven decades, Romsons has built a trusted presence in medical devices and hygiene products, supported by its understanding of the Indian healthcare market and its growing portfolio of products and capabilities.
As healthcare delivery and medical technology continue to evolve, the company sees significant opportunities to expand its footprint, strengthen its product portfolio and build a globally relevant Indian healthcare enterprise.
Strengthening the Next Chapter of Romsons’ Journey
The partnership marks a new chapter in Romsons’ 70-year legacy, combining its strong Indian foundation with global expertise and institutional capabilities.
The company’s immediate focus will remain on strengthening its core business and investing across products, manufacturing, technology and people. Romsons will continue to build a stronger platform while responding to the evolving needs of healthcare markets in India and overseas.
Temasek’s global experience, institutional capabilities and long-term perspective are expected to complement Romsons’ operating strengths and market understanding. As part of the partnership, Romsons and Temasek will also evaluate strategic partnerships and acquisitions in India and overseas where these are aligned with the company’s objectives.
Strengthening Governance and Institutional Capabilities
As Romsons enters this phase of its journey, the company will continue to place strong emphasis on governance, institutional processes and disciplined execution.
Strengthening these areas will be important as the company scales its operations, builds organisational capabilities and prepares for emerging opportunities in the medical devices and healthcare sector.
Looking ahead, Romsons remains focused on building a sustainable healthcare business with the capabilities, scale and institutional strength required to participate in the sector’s evolution. This also includes evaluating the possibility of accessing public markets at an appropriate time, subject to the company’s business trajectory and prevailing market conditions.
Commenting on the development, Mr. Kishore Narain Khanna, Managing Director, Romsons Group, said:
“Welcoming Temasek as a long-term strategic partner marks an important milestone in Romsons’ 70-year journey. We have built Romsons on a strong foundation in the Indian healthcare market, and this partnership gives us an opportunity to take that foundation forward with greater scale, capabilities and a global perspective. Our focus will remain on strengthening the business, investing in our products, manufacturing, technology and people, while continuing to build a trusted and sustainable healthcare enterprise. We look forward to working with Temasek as we enter this new chapter.”
Commenting on the partnership, Mr. Sanjeev Kharbanda, Group CFO, Romsons Group, said:
“Temasek’s investment marks an important step in Romsons’ institutional evolution and provides a strong foundation for the company’s future. As we scale the business, our focus will remain on disciplined capital allocation, strengthening financial and governance processes, and making strategic investments across manufacturing, technology, products and people. We believe this partnership will enhance our ability to pursue opportunities responsibly while maintaining a strong and sustainable financial foundation.”
